Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
29 August 2016 |
Main ID: |
NCT02722629 |
Date of registration:
|
09/03/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Prevalence of Respiratory Aspiration in Patients With COPD
|
Scientific title:
|
Prevalence of Respiratory Aspiration in Patients With COPD: Cross-sectional Study |
Date of first enrolment:
|
June 2016 |
Target sample size:
|
330 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02722629 |
Study type:
|
Interventional |
Study design:
|
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Argentina
| | | | | | | |
Contacts
|
Name:
|
Bruno Ferreyro, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital Italiano de Buenos Aires |
|
Name:
|
Federico Sala, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital Italiano de Buenos Aires |
|
Name:
|
Diego DG Giunta, MD |
Address:
|
|
Telephone:
|
+54 11 49590200 |
Email:
|
diego.giunta@hospitalitaliano.org.ar |
Affiliation:
|
|
|
Name:
|
Diego h Giunta, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital Italiano de Buenos Aires |
|
Name:
|
Diego H Giunta, MD |
Address:
|
|
Telephone:
|
+54 9 11 5825-6489 |
Email:
|
diego.giunta@hospitalitaliano.org.ar |
Affiliation:
|
|
|
Name:
|
Fernando Warley, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital Italiano de Buenos Aires |
|
Name:
|
Hernan Benito, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital Italiano de Buenos Aires |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria
- Patients over 64 years diagnosed with chronic obstructive pulmonary disease guide GOLD
criteria (FEV1 / FVC ratio post bronchodilator <0.70)
Exclusion Criteria
- Refusal to participate or to process oral informed consent
- Contraindication for the FEESST (history of vasovagal episodes, bilateral nasal
obstruction, impaired homeostasis or frequent bleeding, dyskinesia, maxillofacial
trauma or recent neck).
- Impaired understanding or cognition that hinder the consent or performing diagnostic
tests required.
- Diagnosis of neurodegenerative disease associated with swallowing disorders known:
Parkinson, stroke with neurologic sequelae.
Age minimum:
65 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
COPD
|
Intervention(s)
|
Procedure: FEESST
|
Primary Outcome(s)
|
Presence of any consistence Airway Aspiration
[Time Frame: Baseline (Time 0)]
|
Secondary Outcome(s)
|
Aspiration Risk
[Time Frame: Baseline (Time 0)]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|